[Hypersensitivity against vasopressin and the synthetic vasopressin-analog DDAVP].
D000281:Administration, Intranasal; D000328:Adult; D001127:Arginine Vasopressin / Q000276:immunology*; D001249:Asthma / Q000276:immunology; D003894:Deamino Arginine Vasopressin / Q000276:immunology* / Q000627:therapeutic use; D003919:Diabetes Insipidus / Q000188:drug therapy; D004342:Drug Hypersensitivity / Q000276:immunology*; D006801:Humans; D008297:Male; D011658:Pulmonary Fibrosis / Q000276:immunology; D014667:Vasopressins / Q000008:administration & dosage / Q000276:immunology* / Q000627:therapeutic use
D014667:Vasopressins; D001127:Arginine Vasopressin; D003894:Deamino Arginine Vasopressin
Uberempfindlichkeit genen Vasopressin und das synthetische Vasopressin-Analogon DDAVP.